Becton Dickinson and Company

Healthcare · Medical Instruments & Supplies

181.40$ -0.3% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Becton Dickinson and Company (BDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 21,839 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BDX
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	2,770	2,811	3,117	3,418	3,618	3,754	3,960	4,464	4,935	5,415	5,738	6,360	7,075	6,987	7,124	7,584	7,708	8,054	8,446	10,282	12,483	12,093	15,983	17,290	16,074	19,131	18,870	19,372	20,178	21,839
Cost of Revenue	1,229	1,204	1,312	1,453	1,560	1,913	2,049	2,297	2,500	2,662	2,793	3,072	3,447	3,312	3,428	3,625	3,755	3,883	4,145	5,587	6,492	6,128	8,714	9,002	9,276	10,500	10,393	11,202	11,053	11,915
Gross Profit	1,541	1,607	1,805	1,966	2,058	1,841	1,911	2,167	2,434	2,753	2,945	3,288	3,628	3,675	3,696	3,959	3,953	4,171	4,301	4,695	5,991	5,965	7,269	8,288	6,798	8,631	8,477	8,170	9,125	9,924
Research & Development	–	181	218	254	224	212	207	224	236	272	302	360	396	405	423	470	472	494	550	632	828	770	1,004	1,062	1,039	1,279	1,256	1,237	1,190	1,264
Selling, General & Administrative	909	766	862	932	974	983	1,032	1,207	1,311	1,450	1,537	1,602	1,715	1,705	1,721	1,852	1,923	2,422	2,145	2,563	3,005	44	13	2.0	7.0	1.0	4,709	4,719	4,857	5,278
Total Operating Expenses	1,110	1,157	1,308	1,445	1,486	1,195	1,236	1,406	1,647	1,722	1,803	2,085	2,091	2,085	2,114	2,293	2,395	2,917	2,695	3,621	4,561	4,443	5,760	6,528	5,886	6,381	6,195	6,059	6,728	7,347
Operating Income	431	451	496	521	572	646	674	761	787	1,030	1,141	1,203	1,537	1,590	1,582	1,666	1,558	1,254	1,606	1,074	1,430	1,522	1,509	1,760	912	2,250	2,282	2,111	2,397	2,578
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36	40	51	84	135	138	135	371	388	521	706	639	528	469	398	452	528	613
Pre-Tax Income	394	423	341	373	520	577	627	722	753	1,005	1,126	1,204	1,538	1,579	1,567	1,618	1,472	1,165	1,522	739	1,074	976	1,173	1,176	414	1,692	1,783	1,662	2,005	1,882
Income Tax Expense	110	123	104	97	127	138	148	167	170	313	311	348	423	411	452	417	363	236	337	44	98	-124	862	-57	62	88	148	132	300	204
Net Income	284	300	237	276	393	402	480	547	467	722	752	890	1,127	1,232	1,318	1,271	1,170	1,293	1,185	695	976	1,100	311	1,233	874	2,092	1,779	1,484	1,705	1,678
EBITDA	632	660	725	780	861	952	971	1,097	1,144	1,418	1,597	1,767	2,052	2,084	2,109	2,196	2,118	1,849	2,219	2,001	2,576	2,585	3,857	4,068	3,057	4,391	4,410	4,402	4,819	4,957

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings